リキッドバイオプシーの世界市場2017-2021...市場調査レポートについてご紹介

【英文タイトル】Global Liquid Biopsy Market 2017-2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Key market highlights
• Biopsy
• Liquid biopsy: Future of cancer diagnostics

PART 05: Market landscape
• Market overview
• Clinical trials
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by product
• CTCs and ctDNA
• Exosomes and RNA

PART 07: Market segmentation by end-user
• Global liquid biopsy market by end-user in 2016
• Hospitals
• Clinical diagnostic laboratories
• Physicians’ office laboratories

PART 08: Geographical segmentation
• Liquid biopsy market in Americas
• Liquid biopsy market in US
• Liquid biopsy market in EMEA
• Liquid biopsy market in UK
• Liquid biopsy market in APAC
• Liquid biopsy market in China

PART 09: Market drivers
• Increasing prevalence of cancer cases in older population
• Government initiatives and pilot programs
• Collaboration between companies for co-development of products

PART 10: Impact of drivers

PART 11: Market challenges
• Lack of reimbursement
• Dearth of skilled professionals, laboratory technicians, and oncologists
• High cost of clinical trials and failure rate in clinical trials

PART 12: Impact of drivers and challenges

PART 13: Market trends
• Focus on chip development as novel product
• Venture capitals for market entry of start-ups
• Direct-to-consumer laboratory testing

PART 14: Vendor landscape
• Competitive landscape

PART 15: Key vendor analysis
• Biocept
• Exosome Diagnostics
• QIAGEN
• Roche Molecular Diagnostics
• Key companies to watch
• Other prominent vendors

PART 16: Appendix
• List of abbreviations

[List of Exhibits]

Exhibit 01: Comparison: Liquid biopsy and tissue biopsy methods
Exhibit 02: Types of liquid biopsy tests
Exhibit 03: Market overview: Global liquid biopsy market
Exhibit 04: Pipeline of liquid biopsy in Americas
Exhibit 05: Pipeline of liquid biopsy in Europe
Exhibit 06: Pipeline of liquid biopsy in APAC
Exhibit 07: Global liquid biopsy market 2016-2021 ($ millions)
Exhibit 08: Global liquid biopsy potential market 2016
Exhibit 09: Market scenario: Market impact analysis of global liquid biopsy market ($ millions)
Exhibit 10: Five forces analysis
Exhibit 11: Global liquid biopsy market segmentation by product 2016
Exhibit 12: Market overview: CTCs and ctDNA
Exhibit 13: Market overview: Exosomes and RNA
Exhibit 14: Revenue generated by diagnostic and medical laboratories in US 2009-2014 ($ millions)
Exhibit 15: Global liquid biopsy market by geography 2016 and 2021
Exhibit 16: Market overview: Liquid biopsy market in Americas
Exhibit 17: New cancer cases and cancer deaths in US 2015-2020 (per 100,000 population)
Exhibit 18: Global liquid biopsy market in Americas 2016-2021 ($ millions)
Exhibit 19: Market impact analysis: Liquid biopsy market in Americas
Exhibit 20: Market overview: Liquid biopsy market in US
Exhibit 21: Market overview: Liquid biopsy market in EMEA
Exhibit 22: Global liquid biopsy market in EMEA 2016-2021 ($ millions)
Exhibit 23: Market impact analysis: Liquid biopsy market in EMEA
Exhibit 24: Market overview: Liquid biopsy market in UK
Exhibit 25: Market overview: Liquid biopsy market in APAC
Exhibit 26: Colorectal cancer mortality per 100,000 individuals in APAC 2003 and 2013
Exhibit 27: Global liquid biopsy market in APAC 2016-2021 ($ millions)
Exhibit 28: Market impact analysis: Liquid biopsy market in APAC
Exhibit 29: Market overview: Liquid biopsy market in China
Exhibit 30: Older population with cancer in US
Exhibit 31: Government initiatives for cancer and liquid biopsy testing in some countries
Exhibit 32: Market impact analysis: Collaboration between medical device and pharmaceutical companies for liquid biopsy
Exhibit 33: Impact of drivers
Exhibit 34: Number of skilled physicians per 1,000 population 2014
Exhibit 35: Impact of drivers and challenges
Exhibit 36: Market impact analysis: Focus on novel product development by institutes and companies
Exhibit 37: Collaboration of companies with venture capitalists
Exhibit 38: Competitive structure analysis of global liquid biopsy market 2016
Exhibit 39: Competitive landscape analysis of global liquid biopsy market 2016
Exhibit 40: Strategic recommendation for vendors in the global liquid biopsy market
Exhibit 41: Biocept: Key highlights
Exhibit 42: Biocept: Strength assessment
Exhibit 43: Biocept: Strategy assessment
Exhibit 44: Biocept: Opportunity assessment
Exhibit 45: Exosome Diagnostics: Key highlights
Exhibit 46: Exosome Diagnostics: Strength assessment
Exhibit 47: Exosome Diagnostics: Strategy assessment
Exhibit 48: Exosome Diagnostics: Opportunity assessment
Exhibit 49: QIAGEN: Key highlights
Exhibit 50: QIAGEN: Strength assessment
Exhibit 51: QIAGEN: Strategy assessment
Exhibit 52: QIAGEN: Opportunity assessment
Exhibit 53: Roche Molecular Diagnostics: Key highlights
Exhibit 54: Roche Molecular Diagnostics: Strength assessment
Exhibit 55: Roche Molecular Diagnostics: Strategy assessment
Exhibit 56: Roche Molecular Diagnostics: Opportunity assessment
Exhibit 57: Key companies: Global liquid biopsy market


【レポート販売概要】

■ タイトル:リキッドバイオプシーの世界市場2017-2021
■ 英文:Global Liquid Biopsy Market 2017-2021
■ 発行日:2017年3月13日
■ 調査会社:Technavio
■ 商品コード:IRTNTR12229
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。